(Q22330790)

PubMed

PubMed publication ID

8 February 2023

Jenny P-Y Ting

2

Jenny P-Y

Ting

1 reference

PubMed

PubMed publication ID

15653312

Current Opinion in Immunology

8 February 2023

language of work or name

English

0 references

publication date

February 2005

0 references

published in

0 references

volume

17

0 references

issue

1

0 references

page(s)

58-64

0 references

cites work

An epigenetically altered tumor cell vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Genetic control of MHC class II expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

The molecular biology of the CCAAT-binding factor NF-Y

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Transcriptional regulation of the MHC class II antigen presentation pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Role of the CCAAT-binding protein CBF/NF-Y in transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

CREB regulates MHC class II expression in a CIITA-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

DNA methylation and expression of major histocompatibility complex class I and class II transactivator genes in human developmental tumor cells and in T cell malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Chromatin remodeling and extragenic transcription at the MHC class II locus control region.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Enhancement of CIITA transcriptional function by ubiquitin

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

TAF(II)250-independent transcription can be conferred on a TAF(II)250-dependent basal promoter by upstream activators

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

The histone acetyltransferase domains of CREB-binding protein (CBP) and p300/CBP-associated factor are not necessary for cooperativity with the class II transactivator

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Differential ubiquitination defines the functional status of the tumor suppressor Smad4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Class II major histocompatibility complex transactivator (CIITA) inhibits matrix metalloproteinase-9 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma).

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

The S box of major histocompatibility complex class II promoters is a key determinant for recruitment of the transcriptional co-activator CIITA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Control of CBP co-activating activity by arginine methylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Methylation at arginine 17 of histone H3 is linked to gene activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

A transcriptional switch mediated by cofactor methylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Class II transactivator: mastering the art of major histocompatibility complex expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

A 36-amino-acid region of CIITA is an effective inhibitor of CBP: novel mechanism of gamma interferon-mediated suppression of collagen alpha(2)(I) and other promoters

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Histone Deacetylase 1/mSin3A Disrupts Gamma Interferon-Induced CIITA Function and Major Histocompatibility Complex Class II Enhanceosome Formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

B-cell control region at the 5' end of a major histocompatibility complex class II gene: sequences and factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Regulation of MHC class II genes: lessons from a disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Regulation of major histocompatibility complex class II gene expression in trophoblast cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Steroid receptor coactivator 1 links the steroid and interferon gamma response pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021

Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.COI.2004.11.008

7 January 2021